Ashish Verma MD

Assistant Professor, Nephrology

650 Albany St | (617) 638-7339
ashverma@bu.edu

Sections

Nephrology

Biography

Dr. Verma is a clinician-investigator interested in chronic kidney disease (CKD), renal amyloidosis, cardiorenal syndrome, diabetic kidney disease (DKD), renal physiology, and electrolyte abnormalities. Dr. Verma's research projects include epidemiologic investigations utilizing large databases and translational and patient-oriented research projects. Ongoing studies include predictors of CKD progression using CRIC cohort and UK biobank, predictors of mortality using NHANES, a Physiology study examining the role of Kidney Function Reserve and renal plasma flow in phenotyping chronic kidney disease, and the role of intravitreal VEGF inhibitors in causing nephrotoxicity, and renal physiology of decongestion in patients with Acute decompensated heart failure(ADHF). Dr. Verma is a member of the APRC committee for the Framingham Heart Study, the Renal subgroup for clinical endpoints in Amyloidosis for the Amyloidosis research consortium, and the Membership Committee for Kidney in Cardiovascular Medicine for the American Heart Association. He is on the Editorial Board of Therapeutic Advances in Endocrinology and Metabolism, Therapeutic Advances in Chronic Disease, Plos One, and BMC Medicine.

Websites

Education

Medicine, MBBS, Stanley Medical School

Publications

Published on 5/2/2025

Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 May 02; 10(3):767-771. PMID: 39981782.

PubMed

Published on 4/1/2025

Kar D, Byng R, Sheikh A, Nath M, Zabeen B, Kar S, Banu S, Sarker MHR, Khan N, Acharjee D, Islam S, Allgar V, Ordóñez-Mena JM, El-Wazir A, Song S, Verma A, Kadam U, de Lusignan S. Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort. BMC Nephrol. 2025 Apr 01; 26(1):168. PMID: 40169952.

PubMed

Published on 4/1/2025

Claudel SE, Schmidt IM, Waikar SS, Verma A. Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure. J Am Coll Cardiol. 2025 Apr 01; 85(12):1372-1375. PMID: 40139894.

PubMed

Published on 3/17/2025

Schmidt IM, Verma A, Claudel SE, Palsson R, Srivastava A, Stillman IE, Beck LH, Waikar SS. Genetic Testing in Biopsy-Confirmed Kidney Disease. Kidney Med. 2025 May; 7(5):100994. PMID: 40321977.

PubMed

Published on 3/10/2025

Claudel SE, Verma A. Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review. Circulation. 2025 Mar 11; 151(10):716-732. PMID: 40063723.

PubMed

Published on 2/11/2025

Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome. J Am Soc Nephrol. 2025 Feb 11. PMID: 39932805.

PubMed

Published on 1/7/2025

Agarwal R, Verma A, Georgianos PI. Diuretics in patients with chronic kidney disease. Nat Rev Nephrol. 2025 Apr; 21(4):264-278. PMID: 39775051.

PubMed

Published on 12/27/2024

Schmidt IM, Kefalogianni E, Zhao R, Verma A, Sabbisetti V, Rahman M, Pradhan N, Srivastava A, He J, Chen J, Waikar SS, Herrlich A. Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC). Kidney Med. 2025 Mar; 7(3):100958. PMID: 40071064.

PubMed

Published on 12/20/2024

Anand S, O'Neill-Dee M, Sanchorawala V, Verma A. Light-chain (AL) amyloidosis for nephrologists-treatment standard. Nephrol Dial Transplant. 2024 Dec 20; 40(1):34-47. PMID: 39375844.

PubMed

Published on 12/11/2024

Claudel SE, Verma A. Social Determinants of Health and Cumulative Incidence of Mortality Among US Adults Without Major Chronic Diseases. J Gen Intern Med. 2024 Dec 11. PMID: 39663346.

PubMed

View full list of 69 publications.